2 Stocks to Buy This Week With $1 Trillion Upside Potential

The article argues Tesla and Rivian each have a path to add about $1 trillion in market value, driven by Tesla's robotaxi opportunity and Rivian's upcoming R2 SUV. Tesla is cited as already having reached a $1 trillion valuation, with Wedbush's Dan Ives seeing robotaxis alone as a potential $1 trillion market-cap catalyst. Rivian, currently around a $20 billion market cap, could benefit from mass-market vehicle launches, AI autonomy investments, and Uber's commitment to invest up to $1.25 billion for R2 access.

Analysis

The market is effectively being asked to underwrite two very different option structures: TSLA is a late-stage platform bet with visible monetization paths, while RIVN is a pre-scale execution bet with binary financing and product-risk embedded. The key second-order effect is that both names pull capital, talent, and supplier attention toward software-defined vehicles, but only one has the balance sheet and installed base to absorb a delay in monetization. That makes the upside asymmetry much cleaner in TSLA; RIVN’s upside is real, but it is far more sensitive to a single launch cycle and capital market conditions.

The biggest miss in consensus is that autonomy optionality is not equally valuable across the two companies. For TSLA, even modest progress can be amplified by an existing fleet, data flywheel, and consumer awareness; for RIVN, autonomy is currently a narrative bridge to justify a valuation that still depends on proving unit economics at mass-market price points. In other words, the market is likely to overestimate how much strategic value a robotaxi narrative contributes before R2 demonstrates repeatable gross margin and demand elasticity.

From a timing perspective, TSLA’s rerating catalyst is months, not days: product execution, regulatory signaling, and proof of deployment matter more than headlines. RIVN has a more compressed window because the R2 launch and adjacent partnership validation need to show that demand is broad enough to support volume growth without heavy incremental discounting. If deliveries or ramp quality slip, the stock can re-rate sharply lower because the equity story is still mostly promise, not cash flow.

A more contrarian angle is that Uber may be the cleaner way to express the autonomous mobility thesis than either OEM. It can own the demand aggregation layer without manufacturing risk, and any credible fleet supply agreement de-risks its future margin mix. Meanwhile, the current optimism likely underprices the financing dilution embedded in RIVN’s scale-up path; that dilution can erase a meaningful portion of headline upside even if the product launch succeeds.

Key Decisions for Investors

• Long TSLA vs short RIVN as a 6-12 month relative-value trade: TSLA has the stronger operating base and cleaner path to monetize autonomy; RIVN’s upside is more dilution-sensitive and launch-dependent.
• Buy TSLA out-of-the-money calls with 9-15 month tenor to express robotaxi optionality; prefer defined risk because the payoff is event-driven and can reprice sharply on regulatory or deployment milestones.
• Avoid outright long RIVN until the first R2 delivery data and gross margin trajectory are visible; if taking exposure, use a small starter position only after confirmed ramp, not before.
• Consider a UBER long as a lower-beta autonomy beneficiary versus OEMs: the thesis improves if fleet partnerships expand, and downside is cushioned by the core mobility network effect.
• If TSLA runs hard on autonomy headlines, sell upside via call spreads rather than chasing common stock; the market is likely to overreact to narrative before hard volume evidence arrives.